Sector: Healthcare | Industry: Pharmaceuticals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 865 N. Albion St., Suite 300 DENVER CO 80220 |
Tel: | N/A |
Website: | medicinemantechnologies.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Company's business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Company's general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities. |
Financial Overview |
For the fiscal year ended 31 December 2023, Medicine Man Technologies Inc revenues increased 8% to $172.4M. Net loss applicable to common stockholders increased 63% to $42.7M. Revenues reflect Retail segment increase of 10% to $155.5M. Higher net loss reflects Selling/General/Admin Expense increase of 37% to $39.9M (expense), Salaries increase of 14% to $23.9M (expense). |
Employees: | 729 as of Mar 1, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $191.31M as of Dec 31, 2023 |
Annual revenue (TTM): | $172.45M as of Dec 31, 2023 |
EBITDA (TTM): | $26.02M as of Dec 31, 2023 |
Net annual income (TTM): | -$42.70M as of Dec 31, 2023 |
Free cash flow (TTM): | $1.59M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $137.10M as of Dec 31, 2023 |
Shares outstanding: | 77,438,379 as of Mar 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |